Parke-Davis Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3
Founded: Detroit MI United States (1867)
Status: Acquired by Warner Lambert (1970) → now Pfizer (2000)

Organization Overview

First Clinical Trial
1991
NCT00283335
First Marketed Drug
1940
oxtriphylline (choledyl)
First NDA Approval
1940
oxtriphylline (choledyl)
Last Known Activity
2000

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

PARKE DAVIS | PARKE-DAVIS